Abstract:Bone fragility fractures are caused by low bone mass or impaired bone quality. Osteoblast/osteoclast coordination determines bone mass, but the factors that control bone quality are poorly understood. Osteocytes regulate osteoblast and osteoclast activity on bone surfaces but can also directly reorganize the bone matrix to improve bone quality through perilacunar/canalicular remodeling; however, the molecular mechanisms remain unclear. We previously found that deleting the transcriptional regulators Yes‐associated protein (YAP) and transcriptional co‐activator with PDZ‐motif (TAZ) from osteoblast‐lineage cells caused lethality in mice due to skeletal fragility. Here, we tested the hypothesis that YAP and TAZ regulate osteocyte‐mediated bone remodeling by conditional ablation of both YAP and TAZ from mouse osteocytes using 8 kb‐DMP1‐Cre. Osteocyte‐conditional YAP/TAZ deletion reduced bone mass and dysregulated matrix collagen content and organization, which together decreased bone mechanical properties. Further, YAP/TAZ deletion impaired osteocyte perilacunar/canalicular remodeling by reducing canalicular network density, length, and branching, as well as perilacunar flourochrome‐labeled mineral deposition. Consistent with recent studies identifying TGF‐β as a key inducer of osteocyte expression of matrix‐remodeling enzymes, YAP/TAZ deletion in vivo decreased osteocyte expression of matrix proteases MMP13, MMP14, and CTSK. In vitro, pharmacologic inhibition of YAP/TAZ transcriptional activity in osteocyte‐like cells abrogated TGF‐β‐induced matrix protease gene expression. Together, these data show that YAP and TAZ control bone matrix accrual, organization, and mechanical properties by regulating osteocyte‐mediated bone remodeling. Elucidating the signaling pathways that control perilacunar/canalicular remodeling may enable future therapeutic targeting of bone quality to reverse skeletal fragility. © 2019 American Society for Bone and Mineral Research.

YAP1 is Essential for Osteoclastogenesis Through a TEADs-dependent Mechanism

Yap1 Regulates Multiple Steps of Chondrocyte Differentiation during Skeletal Development and Bone Repair

YAP promotes osteogenesis and suppresses adipogenic differentiation by regulating β-catenin signaling

Reciprocal Inhibition of YAP/TAZ and NF-κB Regulates Osteoarthritic Cartilage Degradation

YAP1 Inhibits the Induction of TNF‐α‐stimulated Bone‐resorbing Mediators by Suppressing the NF‐κB Signaling Pathway in MC3T3‐E1 Cells

Yap1 Influences Differentiation Of Osteoblastic Mc3t3-E1 Cells Through The Regulation Of Id1

Hippo/YAP1 promotes osteoporotic mice bone defect repair via the activating of Wnt signaling pathway

The Role of YAP Transcription Coactivator in Regulating Stem Cell Self-Renewal and Differentiation.

A Coordinated Phosphorylation By Lats And Ck1 Regulates Yap Stability Through Scf Beta-Trcp

Both Tead-Binding and Ww Domains Are Required for the Growth Stimulation and Oncogenic Transformation Activity of Yes-Associated Protein

TEAD Mediates YAP-dependent Gene Induction and Growth Control

YAP1 Negatively Regulates Chondrocyte Differentiation Partly by Activating the Β-Catenin Signaling Pathway.

Integration of Mechanical and Chemical Signals by YAP and TAZ Transcription Coactivators.

YAP/TEAD1 and Β‐catenin/lef1 Synergistically Induce Estrogen Receptor Α to Promote Osteogenic Differentiation of Bone Marrow Stromal Cells

YAP1/TAZ Mediates Rumen Epithelial Cell Proliferation but Not Short-Chain Fatty Acid Metabolism in Vitro

A YAP/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis.

YAP Modulates TGF-β1-induced Simultaneous Apoptosis and EMT Through Upregulation of the EGF Receptor

Up-regulation of FOXD1 by YAP Alleviates Senescence and Osteoarthritis.

Skeletal cell YAP and TAZ combinatorially promote bone development

YAP and TAZ Mediate Osteocyte Perilacunar/Canalicular Remodeling

YAP Balances the Osteogenic and Adipogenic Differentiation of Hpdlscs in Vitro Partly Through the Wnt/β-catenin Signaling Pathway.